Similar articles

Abstract: Purpose: To investigate the relationship between expression of cell cycle-related protein cyclin D1, p27kip1 and the pathogenesis of bronchioloalveolar carcinoma (BAC) and the value of prediction of prognosis. Methods: cyclin D1 and p27kip1 protein were detected by immunohistochemical En Vision method in 43 BACs. Results: The positivity of cyclin D1 in BAC was 65.1% (28/43), which was significantly higher than that in normal pulmonary tissue (0/13), P<0.01. No statistically significant association was found between cyclin D1 expression data and sex, age, tobacco-use history, histologic subtype (mucinous vs nonmucinous), stromal fibrosis, lymph node metastasis, clinical stage or postoperative survival period (P>0.05), while cyclin D1 expression was found to be negatively correlated with tumor size (P<0.05). The positivity of p27kip1 in BACs was 51.2% (22/43), significantly lower than that in normal pulmonary tissue (12/13), P<0.01. p27kip1 expression level was not associated with sex, age, tobacco-use history, tumor size or histologic subtype (P>0.05), but was negatively correlated with stromal fibrosis, lymph node metastasis and clinical stage (P<0.05); and positively associated with postoperative survival period (P<0.01). The survival rate of p27kip1 positive group was significantly higher than that of p27kip1 negative group (P<0.01). No statistically significant correlation was found between cyclin D1 and p27kip1 expression. Conclusions: Increased cyclin D1 expression and decreased p27kip1 expression are related to the pathogenesis of BAC; decreased p27kip1 expression is associated with metastasis progression; immunodetection of p27kip1 is useful for assessment of prognosis.

[1] Bartkova, J., Luks, J., Muller, H., 1994. Cyclin D1 protein expression and function in human breast cancer.Int J cancer,57:353-361.

[2] Bombi, J.A., Martinez, A., Ramirez, J., 2002. Ultrastructural and molecular heterogeneity in non-small cell lung carcinomas: study of 110 cases and review of the literature.Ultrastruct Pathol,26(4):211-218.

[3] Chiarle, R., Budel, L.M., Skolnik, J., 2000. Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantal cell lymphoma.Blood,95(2):619-626.

[4] Fu, J., Shi, C.X., Li, X.G., 2000. Significance of p16, cyclin D1 and nm23 protein expression in Non-small cell lung cancer.J Diag Pathol,7(1):36-38 (in Chinese).

[5] Harris, A.W., Bodrug, S.E., Warnce, B.J., 1995. Cyclin D1 as the putative bel I oncogene.Curr Top Microbiol Immunol,194:347-353.

[6] Hommura, F., Dosaka-Akita, H., Mishina, T., 2000. Prognostic significance of p27kip1 protein and Ki-67 grow fraction in non-small cell lung cancer.Clin Cancer Res,6(10):4073-4081.

[7] Hui, A.M., Cui, X., Makuuchi, M., 1999. Decreased p27 (kip1) expression and cyclin D1 overexpression, alone and in combination, influence recurrence and survival of patients with resectable extrahepatic bile duct carcinoma.Hepatology,30(5):1167-1173.

[8] Kurasono, Y., Ito, T., Kameda, Y., 1998. Expression of cyclin D1, retinoblastoma gene protein, and p16MTS1 protein in atypical adenomatous hyperplasia and adenocarcinoma of the lung. An immunohistochemical analysis.Virchows Arch,432(3):207-215.

[9] Li, B.Q., Li, Q.Q., Pang, X.G., 1999. Expression and significance of cyclin D1 in lung carcinoma.Chin J Tuberc Respir Dis,22(5):316 (in Chinese with English abstract).

[10] McDonald, J.W., Pilgram, T.K., 1999. Nuclear expression of p53, p21 and cyclin D1 is increased in bronchioloalveolar carcinoma.Histopathology,57:439-446.

[11] Nguyen, V.N., Mirejovsky, P., Mirejovsky, T., 2000. Expression of cyclin D1, Ki-67 and PCNA in non-small cell lung cancer: prognostic significance and comparison with p53 and bcl-2.Acta Histochem,102(3):328-338.

[12] Nohara, T., Ryo, T., Iwamoto, S., 2001. Expression of cell-cycle regulator p27 is correlated to the prognosis and ER expression in breast carcinoma patients.Oncology,60(1):94-100.

[13] Tominaga, M., Sueoka, N., Irie, K., 2003. Detection and discrimination of preneoplastic and early stages of lung adenocarcinoma using hnRNP B1 combined with the cell cycle-related markers p16, cyclin D1, and Ki-67.Lung Cancer,40(1):45-53.

[14] Tsihlias, J., Kapusta, L.R., DeBoer, G., 1998. Loss of cyclin-dependent kinase inhibitor p27kip1 is a novel prognostic factor in localized human prostate adenocarcinoma.Cancer Res,58:542-548.

[15] Xie, B.S., Li, Q., Liu, Z.L., 1999. Relation between expression of cyclin D1 and biological behavior in non-small cell lung cancer.Acad J Sec Mil Univ,20(12):980-982 (in Chinese with English abstract).